Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Capitalistaon Nov 11, 2022 7:44am
268 Views
Post# 35090742

RE:RE:RE:RE:ONCY Goblet-1 trial pancreatic trial -> COMPLETE RESPONSE !

RE:RE:RE:RE:ONCY Goblet-1 trial pancreatic trial -> COMPLETE RESPONSE !

westcoast1000 wrote:

But your notion of large trials is a good idea. That is because if pela helps your immune system kill off nascent tumers, we may not even know they had been there!


Exactly, WC1000.  If the immune system can be primed through Pela/CI action (or even just Pela) to destroy nascent tumours (or even individual cancer cells before they form what can be called a tumour) the incidence of "successful" cancer in a population could be considerably reduced. 
 

The economics of this, however, would be tricky.  To be taken up as a "vaccine" model, the price would have to be much lower than that used for treatment of Stage IV cancers.  The production costs may not allow this (not sure how scaleable ONC's technology is).  However, the potential market would be orders of magnitude larger if it proved successful. 

<< Previous
Bullboard Posts
Next >>